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• L n e r  Angloplasty for Within Stent Restenosls - 
Final Results of the LARS 5urvelllsnce Study 
C,W Harem, R Simon, R,J Seabra Gomea, H, Sloven, C, Macaya, 
E, Fleck, J J  Bonn or, R, K0sler, PW. Serruys. The LARS Sfuc/y 
tnv¢$fl~lOt~: Un~t~ty Hospital ERpendo#, H#m~r~, Germ~rry 
Corof~ry ~Imlting is asso¢tat~ with a msleno~ts rotes of 10 to 20%. When 
treated with re~aat PTCA th~ mcgf fe~ rate ~n be as high as 80%. The 
lef~ restdt may b~ mo~ f~vo~l'a~ by 0g~cu!king tissue like with oximer 
I~set com~aw engiol~sly (ELA), 
Met/'m~: In It.s ~ i tve ,  mgit~enler sludy we investigated ~ffety and 
e f f~"Y O! ELA With ad j~ FTCA in ~t i~  (~.70% diaft~_ter stesoeis) 
or ocg~ slenls in 4!4 ve~ (88% n~lW~. !~.  ~in grafts) w~th 494 
steels implanted, The k~sion length was 19,0 ± 13,1 ram with ~_ ~ffomnt 
tyl~. s o! ~lents (25% AVI~. !9% Palmaz.Schatz) implanted 5,8 months puor 
~ -  ~ten0sls diameter was ~ by El-A, to 42 ± 16% and after 
a~u~ PTCA (12.6 ± 4,0 aim) to 7 ± 12%, P ~ I  success, was 
~ in g~=, Col l lp l ica~ aft(IF EL~ were rag*stared in 5? pa.tmnta 
(13.8%) iac.lu~ing 2 r~nor par~0ra~ and 20 d issect~ (48%). Afte~ a~ 
iunctt~ FTCA in 411 ~ Ihere ware 2 more perforations and 45 more 
diSSeCl~nS (10 9%) which re~t~re~ add i~ l  steals in 67 pts (16%). Steal 
da~ (n ; 2) and pencafdml tamponade (n : 2) were rare Dunng hospP 
talt~ation !here were 6 deaths (n = 3 cerebral hemonhages), 2 myocarOal 
in fa~ and t0 non4~wave infarctmns. 
Co~. :  ELA was safe and effectnm in treatment oF restenoses wrlhin 
stents Long term results are pending 
~ R m t  Clink:at I ~ ~  With ~¢u lar  Low 
PcmN~r ad I La~ Light 1RIteralw for IRrevention of  
~ i s  Following COrOnary Stealing 
I. De ,Scheerder, K. Wang, MH Keelan, Jc N Kq~shidze. Univetsa~y 
~ s  L eu~n. Belgium 
Backg~,-ound: Low power red laser light therapy (LPRLT) has been shown to 
reduce msteno~s follo~r, ng balk:~on ang iop~ in animal models. 
Methods: The purpose o! this study was to determine the safety and 
efficacy of LPRLT to pmvant restenosis fol~-~m~ coronary sten~ng. Three 
groups o! patmnts received LPRLT using the coPJ t--et illuminator" (Global 
Therapeutics. Boulder, CO) w~ a laser p'c'.:..'~ cf ~ t J/cm ~. Group I 
II included patients w~th erlher a sut~3pbmai ng~plasty result (n = 26), or 
~r rent  restenos=s after balloon angtuptasty (n = 24). Group III included 20 
patients wdh restenosis following coronary steflting 
Results: The primary success rate was f00%. No maior in-h~spdal com- 
plK:abons occurred dunng this study Thirteen pahents underwent a control 
ang~ogram because el recurrence of an~na pectons A s~gnificant steal 
stenosls was found in only 5 patients Elective coronamgram at 6 months 
was perfon'ned in another 49 pts. Restenos~s (DS ~ 50¢°) was found in 9 pts 
O8.4%). Quanbtatwe coronary analysis per les~on treated: mimmal furmnal 
diameter (MLD) pre: 0.8 ~ 0.5 ram, pest: 2.9 • 0.6 ram. follow.up: 1.9 ± 0.6 
mm. Restenosts rate was 20.6% 
Conctuston: These preliminary results suggest that LPRLT after coronary 
stenting ts feasible and safe and potentially has a benefioal effect on steal 
restenosis in this high risk patient population. A multicenter randomized htal 
to confirm these results is pending. 
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~' -8 - ]  Neointimal and Not Adventiflal Plays Proliferation 
a Role in Restenosis After Percutaneous 
Transluminat Coronary Angioplasty in Humans - 
A Histomorphometric Analysis 
R. Komatsu. M Ueda, T. Naruko, A. Koiima, A.E. Backer. Osaka City 
Umversity Medical School, Osaka, Japan; Academic Medical Center. 
Amsterdam, The Netherlands 
Background: Late vascular ecoil, considered to result from edventitial prolif- 
eration, rather than neointimal formation is presently promoted as the cause 
of restenosis (RS) after percutaneous transfuminal coronan/ angioplasty 
(PTCA) in humans. 
Material and Methods: Of an autopsy senes of 92 post-PTCA patients and 
based on follow-up angiographic dleria, we performed histomorphometdc 
surface area analysis of 18 coronary arteries with RS (;n;~,~al PTCPJdaalh 
= 2 mos ~ 2 yrs) and of 5 coronary arteries with luminal narrowing but 
not meeting the cnlefia of RS (inlewai PTCA/doath = B rues 2 yrsl The 
proximal non~lilated sites flowed as reference 
Result,, All PTCA sites showed ~nt imal  tisstm, albe=l to varying de. 
ureas The moan luminal area at PTCA silos was e=pressea S a ratio C ,t 
rn# mean luminal area af mtom~o sites. This rat~ W~s ~lnificsnfly (p .: 
0,0001) 10w~r at RS sites (0246 _+ 0,104) ttmn st non-RS s~tes (0.692 
0.~40), Area quantification of ~ adverffiti~ showe~ tlo statisli(~tlly s~f~..ant 
~ffomn¢~ t~lwesn RS a~ non-RS I~K~IlS, The tn~n neomliml area was 
@spf~ as # i~liO of 111~ mean lq~l~L~nlife,~l ~re~ ,~ Iumir~! aea~. Th~s fsfio 
W~S significantly (p ~: 0,01 ) I~gher al flS sites (9,779 ± 0, t 08) than at no~- fl$ 
sites (0545 ~ 0,0~.1) The ~ total v~e l  ~rea was s~lnif~mtly (p < ~,01 )
~r  at RS ~!tas (10916 ¢ 2,849 mm ~) fhah at reference sites (92.50 
;2,072 mm ~) 
Conctuag~na: These obse~/atto~s COetradict ~ kw role tar adventttiat 
pfolifor~t~ as a cause of resteno~ls after PTCA in humans, but father 
emphasizes the rote of the neoin~ma 
• Plasma UmkintN  Antigen Levels Predict 
Angmgraphie Res lef lo i I l  
BH. Strauss. I Smgh, H.K. Lau, K.A. Bowman, JM  Teitel. J,O Sparkes, 
MB Gawery, MK Nataraian, R.J Chisholm St M:chae£s Hospital, 
Tomma Canaaa 
Purpose: TO determine the relationship between restenosis and plasma lev. 
els el umkinase anligen (UK), urokioase ~ (uPA), tissue plasmmogen 
activator (tPA), of plesmmogen activator inhibitor (PAl). 
~ :  In a prosgeclwe study enrolling 159 pal~enle (pts), plasma levels 
of UK. uPA. tPA. PAl were drawn immediately before and serially after eteclwe 
PTCA/stenting of a de nova lesion in a native coronary artery Restenosis, 
defined as >50% resK/ual umen diameter slenosis by quantitative coronary 
angmgraphy was datem~ned at 6 months. 
Results: To date. 116 of 126 (92%) of elig=ble pls. have had angJographlc 
toltow~up. In the overa, group, uPA levels showed a significant increase 
at and beyond 3 days postprocedure. The resfenos=s rate was 24%, The 
"restenosis" group had higher UK levels overall (including pre-PTCA) than 
the "no restermsm" group (Figure). No s~gniflcant differences were observed 
in the tPA and PAl levels between I1~ two groups. 
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Conclusions." Plasma urekinase antigen levels identify a group el patients 
at nsk for restenosis post-PTCA Plasma urokinase actnnty levels elevate 
significantly 3 days IDOst-PTCA 
I 1062-1001 Atherosclerotic Progression in the Proximal 
' Non-treated Segment in Patients Undergoing 
Coronary Interventions Evaluated by 
Intravascular Ultrasound 
J. Ge, F bu. G. Gdrge. M Hauda. V. Shah, R ErbeL Dept at Cardlo/og~ 
University Essen. Germany 
B~ckground: Injury of the endothelial cells may result in plaque formallon 
Purpose of the study waS to evaluate the alhemsclemtic hanges in the 
proximal non.treated segments in patients who underwent PTCA 
Metheds: Intravascular ultrasound (IVUS) was performed in 59 patients 
(51 males, aged 55 • 9 yre) immediately pest successful PTCA and 6 months 
follow-up using a 3.5 F, 20/30 MHz IVUS catheter (Sonicalh, Boston ScientiI~c 
Co). The vessel and plaque areas in the proximal and distal non-treated 
reference segments 2 em proximal and disfa! to the intervention segment 
were evaluated 
Resu;rs: No significant differences were found concerning the vessel 
areas between initial 9xaminaticr~ at~d at 6-month it!low-up in the proximal 
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